TI   "Biaxin Listed as Treatment for AIDS-Related Infection"
 SO   Wall Street Journal (12/29/93) P. B4
 AB   Abbott Laboratories Inc. of Abbott Park, Ill., has received approval
      from the Food and Drug Administration to offer its antibiotic Biaxin
      as a treatment for disseminated mycobacterium avium complex (MAC), an
      AIDS-related condition.  Disseminated MAC is the most common systemic
      bacterial infection observed in AIDS patients.  According to Abbott,
      Biaxin, the brand name for clarithromycin, is the first drug to
      receive FDA permission to treat the infection.  The company reported
      study results indicating that Biaxin reduces the MAC organism in the
      blood.

      Copyright (c) 1993 - Information, Inc., Bethesda, MD.  This
      information is provided by the Centers for Disease Control &
      Prevention (CDC), National AIDS Clearinghouse as a public service. 
      Non-profit reproduction is encouraged.

 * Origin: AEGIS/San Juan Capistrano 714.248.2836 (CASAN)  (1:103/927)
 * Provided as a service of THE BACKROOM - NYC * 718-951-8256